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Amniotic membrane has been widely used in regenerative medicine especially ophthalmology. It has many
advantages including anti-inﬂammatory, anti-ﬁbrotic and antimicrobial properties. The purpose of the present
work to study the eﬀect of lyophilized human amniotic membrane on healing of bony defect in rabbits' femur.
Eighteen male rabbits were used. Four mm wide and 5 mm deep defect was created in the femur diaphysis
bilaterally in each rabbit. The defect of the right side was left empty (control), while the left side was ﬁlled with
the amniotic membrane (study). Six rabbits were scariﬁed at each of the experimental periods 2, 4 & 6 weeks
postoperatively. The defect areas were dissected out and evaluated histologically & histomorphometrically. In
the control group, at 2 weeks, woven bone spicules were seen extending from the periphery of the defect
boundaries. At 4 weeks, the newly formed bone became more mature. At 6 weeks, the newly formed bone was
more dense with newly formed osteons were seen. However, in the study group, the newly formed bone was
much less in relation to the control group. Remnants of the amniotic membrane was seen folded at the center of
the defect area surrounded by inﬂammatory cells. Histomorphometrically, the mean percentage of bone surface
area in control group was higher than the study group in all experimental periods and the diﬀerence was statistically signiﬁcant (p < 0.001). It was concluded that: freeze dried amniotic membrane is not suitable to
enhance bone healing when used as a ﬁlling material in bone defects.

1. Introduction

Since the global awareness of virus transmission (e.g. AIDS) increased in 1980s, the use of human amniotic membrane decreased.
However, by the end of the 1990s, new methods for the processing and
cryopreservation of human amniotic membrane were established, and
its use in wound care and reconstructive surgery became of interest
once again [7]. In 2008, more than 2000 human amniotic membrane
transplantations for ophthalmologic reconstructions were performed in
Germany [8].
The amniotic membrane has demonstrated low immunogenicity as
well as re-epithelialization, anti-inﬂammatory, anti-ﬁbrotic, antimicrobial and antitumor properties. This is attributed to its ability to
release biologically active substances, including cytokines and signaling
molecules. These characteristics have recommended its wide use in
regenerative medicine [9–12].
Interestingly, Wang et al. [13] have found that human amnion-derived mesenchymal stem cells stimulated increased levels of alkaline
phosphatase activity (ALP), osteogenic marker genes, and matrix deposition, thus conﬁrming that human amnion-derived mesenchymal

Human amniotic membrane is the inner layer of the fetal membranes (the outer layer being formed by the chorion) and has been
investigated as an alternative biomaterial in reconstructive surgery and
wound healing. It was ﬁrst used in 1910 by Davis [1].
Amniotic membrane use has expanded during the twentieth century
especially as a dressing for burns and facial dermabrasions providing
excellent coverage and healing potential in comparison to conventional
materials [2,3].
Amniotic cells have been proved to produce several growth factors
involved in wound healing as epidermal growth factor, vascular endothelial growth factor, and tissue inhibitors of metalloproteinase 1 and
2 [4].
That's why the biological and immunological properties of amniotic
membrane have made it of special interest for use by clinicians in
management of burn lesions, surgical wounds and ocular surface disorders [5,6].
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stem cells can provide a preferential medium for driving osteogenic
diﬀerentiation in bone marrow mesenchymal stem cells. These observations conﬁrm the capability of human amnion-derived mesenchymal stem cells in the treatment of bone defects.
Most of researches which evaluated eﬀect of amniotic membrane on
bone healing used it as a covering for the bone defect [31] or in combination with bone graft [36]. So, the aim of the present work was to
evaluate histologically and histomorphometrically the bone healing of
the osseous defects (induced in the femur of rabbits) ﬁlled with the
lyophilized human amniotic membrane in comparison to the negative
control bone defects.

2.1. Light microscopic examination
The defect areas were placed in 10% neutral buﬀered formalin for
ﬁxation, washed, decalciﬁed in 10% EDTA, dehydrated in ascending
concentrations of alcohol, cleared in xylene and embedded in paraﬃn
wax. 5 μ thick sections were cut and stained with hematoxylin & eosin
using conventional method [14].
2.2. Histomorphometric analysis
We have chosen to measure the percentage of newly formed bone
because it is the most indicative parameter to assess bone healing [36]
Morphometric evaluation of the newly formed bone in the defect area
was calculated using Image J 1.46r program. Three longitudinal sections were cut from each specimen at diﬀerent standardized depths.
From each section, an image was captured using the same magniﬁcation power. In each image, three rectangles with standardized dimensions were drawn in three regions in the defect including the upper left
border, lower left border and the center of the right border. The surface
area of the rectangle was measured by choosing the region of interest
(ROI) from tools and the measurement was recorded. Within each
rectangle, the bone marrow spaces were selected using wand tracing
tool, measured, and subtracted from the total area of the rectangle to
obtain the area occupied only by bone (Fig. 2).
The results were expressed as percentage values (the proportion of
area occupied only by bone in relation to the total area of the standard
rectangle). The mean percentage of the newly formed bone of three
rectangles in each section was calculated. The same procedure was
repeated for each of the three sections of the same specimen and the
mean was obtained. The same procedure was repeated for each of the
six specimens in each group. The terminology used are those described
by the Histomorphometry Nomenclature Committee of the American
Society for Bone and Mineral Research [15].
Data obtained from histomorphometrical analysis were statistically
described in terms of mean and standard deviation. Analysis of variance
(ANOVA) test was used to compare the values between the diﬀerent
groups. Signiﬁcance level (p value) was 0.05. Values less than 0.05 was
considered statistically signiﬁcant. Statistical analysis was completed
using Statistical Package for the Social Sciences (SPSS) version 20.0
[16].

2. Materials and methods
The present study was approved by the Institutional Ethics
Committee for Animal Use of Alexandria University. Eighteen New
Zealand white male rabbits, about 5 months old, weigh 3–3.5 kg were
used in this study. The left side was assigned as the study side and the
right side assigned as the control side in each animal. Eighteen bone
defects were ﬁlled with amniotic membrane folded in layers and the
other eighteen contralateral defects were left untreated as negative
controls.
Water and food were suspended for the animals 12 h before surgery.
The animals were anesthetized with intraperitoneal injection of 30 mg/
kg ketamine. The anesthesia was maintained with Promazil (1 ml/kg).
The surgeries were carried out at the Institute of Medical Research,
Alexandria University. First, shaving was done in the femoral diaphysis.
An incision about 2 cm long was done on the distal surface of the femur
using a scalpel blade No. 10. Then, a ﬂap was elevated leaving the bone
exposed. Drilling was done using surgical burs, to create bone defects in
each femur of 4 mm diameter and 5 mm depth [31] (Fig. 1a&b). A
sterilized ruler was used to check the dimensions of the defect, and a
depth gauge was used to measure its depth.
The left-sided defect was ﬁlled with the freeze-dried sterile human
amniotic membrane (Biomembrane; manufactured by National Center
for Radiation Research, SAE) folded in layers (Fig. 1c). The right-sided
defect was left empty as the negative control. The wound was sutured in
layers, with absorbable suture of polyglactin. Afterwards, the rabbits
were returned to their cages individually without mobilization of their
extremities.
Analgesia was done with Diclofenac sodium (Voltaren75 mg/3 ml
Solution for Injection) administered intramuscularly. Antibiotic
(Cefotaxime: Cefotax 1 g, Egyptian int. Pharmaceutical industries co.
Eipico) was administrated to rabbits for 5 days following surgery.
Animals were monitored every day after surgery by the researcher, and
veterinary technician.
Six animals were euthanized with an over dose of ketamine (KET A100)at each of the experimental periods 2, 4 & 6 weeks postoperatively.
The femurs of the right and left sides were obtained. The defect area
were dissected out and processed for light microscopic examination and
histomorphometric analysis.

3. Results
3.1. Light microscopic results
3.1.1. After 2 weeks
Histological examination of the healing defect in specimens obtained from the control group revealed the formation of woven bone
which consisted of intercommunicating bony spicules ﬁlling some parts
of the defect. The bone spicules contained abundance of large osteocyte
lacunae and were lined by osteoblast cells. Another part of the defect
was ﬁlled with ﬁbrous connective tissue. Cartilage like tissue was also
seen in-between the newly formed bony trabeculae. Areas where active

Fig. 1. Application of amniotic membrane in the femur bone defect. a) The amniotic membrane, b) bone defect is created in the rabbit's femur, c) the defect is ﬁlled
with the membrane.
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Fig. 2. The surface area of the newly formed bone is measured using Image J 1.46r program. The bone marrow spaces are traced using wand tracing tool.

Fig. 3. Light micrographs (LM) of the defect site (2 weeks) in control group.
(A): Compound LM showing some areas are ﬁlled with newly formed bone
(white asterisk), while other areas is ﬁlled with ﬁbrous connective tissue (black
asterisk). Cartilage like tissue can also be seen (hollow asterisk). The area of
active bone formation is represented with numerous osteoblasts (arrows). B:
Higher magniﬁcation of the previous micrograph inset showing the newly
formed woven trabeculae with rich osteocyte content (arrow heads) and a
continuous layer of osteoblast cells (long arrows) lining the endosteal surface of
bone. The borders of the defect site can be seen (short arrows). (H&E A: mag.
x40, B: x100).

Fig. 4. LM of the defect site (2 weeks) in the study group. (A):Compound LM
showing the defect site is ﬁlled with the folded amniotic membrane (white
asterisk) and ﬁbrous connective tissue (black asterisk). B: Higher magniﬁcation
of the previous micrograph inset showing the amniotic membrane (long arrows)
and the ﬁbrous connective tissue (short arrow) containing some inﬂammatory
cells. (H&E A: mag.40x, B: 100x).

bone formation was taking place were covered with large number of
osteoblasts (Fig. 3A&B).
In the study group, the defect area was ﬁlled with folded amniotic
membrane and ﬁbrous connective tissue containing some inﬂammatory
cells (Fig. 4A&B).

the defect, the remnants of the amniotic membrane appeared folded
and surrounded by inﬂammatory cells (Fig. 6 A&B).

3.1.3. After 6 weeks
In the control group, the healing defect revealed the formation of
more dense well vascularized bone occupying a larger surface area of
the defect in comparison to the four weeks control group. Small osteons
could also be seen. Areas of immature bone rich in osteocytes are
present between mature bone trabeculae. Other areas of the defect
showed formation of widely separated less organized bone trabeculae
(Fig. 7A&B).
In the study group, the total amount of newly formed bone mass was
much less in comparison to the control group. Thin bone trabeculae
were seen extending from all around the defect boundary and lined by
osteoblast cells. Remnant of the membrane still could be seen at the
center of the defect in a folded pattern and surrounded by dense inﬂammatory cells (Fig. 8A and B).

3.1.2. After 4 weeks
In the control group, the newly formed bone was seen ﬁlling a
greater surface area of the defect in relation to the study group. The
newly formed bone trabeculae consisted of mature lamellae containing
regularly arranged osteocyte lacunae and lined by osteoblast cells.
Complete osteointegration was seen between the newly formed bone
and the old bone. At the central part of the trabeculae, darkly stained
immature bone containing numerous osteocyte lacunae was recognized.
At some parts of the defect the newly formed trabeculae were dense,
while in other parts they were few and thin. The central region of the
defect was empty containing scattered bone spicules and some inﬂammatory cells (Fig. 5 A&B).
In the study group, thinner and fewer trabeculae were seen growing
from the defect boundaries. The adjacent part of the defect contained
dense ﬁbrous tissue and numerous inﬂammatory cells. At the center of
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Fig. 7. LM of the defect site (6 weeks) in control group. (A): Compound LM
showing the mass of the newly formed bone ﬁling a large surface area of the
defect site, while other areas contain widely separated trabeculae (asterisks).
(B): Higher magniﬁcation of the previous micrograph inset showing the newly
formed osteons (long arrows) and complete osteointegration (short arrows)
with the native bone. The immature darkly stained bone (hollow asterisks) is
surrounded by mature lightly stained mature bone (solid asterisks). Note the
vascularity (arrow heads) of the newly formed bone. (H&E A: mag.40x, B:
100x).

Fig. 5. LM of the defect site (4 weeks) in the control group. (A): Compound LM
showing the bone trabeculae extending from the defect boundaries. In some
areas the bone trabeculae are thin and few (long arrows), while in other areas
the trabeculae are more dense and numerous (short arrows). (B): Higher
magniﬁcation of the previous micrograph inset showing the organization of the
bone trabeculae. The darkly stained woven bone (hollow asterisks) is surrounded by mature lightly stained trabecular bone (solid asterisks). Note the
osteoblasts lining the outer surface of bone and endosteal surface of the bone
trabeculae (long arrows), a line of integration between the newly formed bone
& native bone (short arrows) and inﬂammatory cells at the center of defect
(arrow heads).(H&E A: mag.40x, B: 100x).

Fig. 8. LM of the defect site (6 weeks) in the study group. (A):The newly formed
bone trabeculae are thin (arrows) and extending from the periphery of the
defect towards its center. The central part of the defect contains remnants of the
amniotic membrane (arrow heads) and dense inﬂammatory cells (asterisks).
(B): Higher magniﬁcation of the previous micrograph inset showing the
structure of the newly formed bone mass and plump-looking osteoblasts at the
forming bone surfaces (arrows). (H&E A: mag.40x, B: 100x).
Fig. 6. LM of the defect site (4 weeks) in the study group. (A): Compound LM
showing the newly formed bone trabeculae growing from the defect boundaries
(arrows). The central region of the defect shows ﬁbrous connective tissue arranged in a circular pattern (hollow asterisks) with some areas containing dense
inﬂammatory cells (solid asterisks). Folded amniotic membrane (arrow heads)
surrounded by inﬂammatory cells can be seen in central part of the defect. (B):
Higher magniﬁcation of the previous micrograph inset showing the structure of
the newly formed bone and osteointegration (long arrows) with the native
bone. Note the adjacent ﬁbrous connective (short arrows) containing dense
inﬂammatory cells (asterisk) and newly formed blood vessels (arrow heads). (H
&E A: mag.40x, B: 100x).

However, there was signiﬁcant decrease in mean percentage of
newly formed bone in study group in comparison to the control group
in all experimental periods at 2, 4 & 6 weeks where p < 0,001.
4. Discussion
Amniotic membrane is derived from the internal layer of fetus
membranes [11]. It has been used since 1940s as a natural scaﬀold
material especially in ophthalmology [17]. It has many advantages
including strength, translucency and ﬂexibility. It contains many cytokines which gives the membrane unique anti-scarring properties [18].
Moreover, in clinical practice, amniotic membrane shows minimum
inﬂammation and microbial infection [19,20]. Tamagawa et al., 2004
were the ﬁrst to explore the pluripotency of cells isolated from human
amniotic membrane [21]. They can diﬀerentiate into a wide variety of
cells [22–24]. Therefore, use of amniotic membrane in regenerative
medicine became a great promise.
Large bony defects are considered very serious complications that
can result from accidents, invasive tumors and infections. If these defects didn't heal properly, serious health related problems may occur.
So, choosing an appropriate graft material will be mandatory to stimulate new bone formation [25].
Kamadjaja et al. (2014) [26] demonstrated that mesenchymal cells
isolated from human amniotic membrane express mesenchymal stem

3.2. Histomorphometric analysis
The percentage of the newly formed bonein both study and control
groups at 2, 4 & 6 weeks are summarized in Table (1) by means and
standard deviation.
In control group, there was signiﬁcant increase (p1, p2& p3 < 0.05)
in mean percentage of bone surface area through all the 3 experimental
periods where the values were 42.67 ± 3.56, 54.67 ± 5.39&
69.33 ± 6.65 at 2, 4 & 6 weeks respectively. In addition, in the study
group, there was also signiﬁcant increase (p1, p2& p3 < 0.05) in mean
percentage of bone surface area through all the 3 experimental periods
where the values were 2.58 ± 1.07, 17.33 ± 4.72&30.33 ± 6.38 at
2, 4 & 6 weeks respectively.
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Table 1
Comparison between the diﬀerent studied periods and groups according to percentage of bone surface area (%).
Bone surface area (%)

2 Weeks (n = 6)

4 Weeks (n = 6)

6 Weeks (n = 6)

F

p

Control group
Min. – Max.
Mean ± SD.
Median

39.0–48.0
42.67 ± 3.56
42.0

47.0–60.0
54.67 ± 5.39
56.50

60.0–77.0
69.33 ± 6.65
69.50

34.351∗

< 0.001∗

Sig. bet. periods.

p1 = 0.002∗,p2 < 0.001∗,p3 = 0.019∗

Study group
Min. – Max.
Mean ± SD.
Median

1.50–4.50
2.58 ± 1.07
2.25

20.0–37.0
30.33 ± 6.38
31.0

53.239∗

< 0.001∗

Sig. bet. periods.

p1 = 0.001∗,p2 < 0.001∗,p3 = 0.009∗

T
P

26.422∗
< 0.001∗

11.0–22.0
17.33 ± 4.72
19.0

12.764∗
< 0.001∗

10.366∗
< 0.001∗

F, p: F, p values for Post Hoc test (LSD) for ANOVA with repeated measures for comparison between diﬀerent periods.
t, p: t and p values for Student t-test for comparing between the two groups.
p1: p value for comparing between 2 weeks and 4 weeks.
p2: p value for comparing between 2 weeks and 6 weeks.
p3: p value for comparing between 4 weeks and 6 weeks.
*: Statistically signiﬁcant at p ≤ 0.05.

cells surface markers (CD105 and CD90) and can diﬀerentiate into osteoblast cells when cultured in vitro in osteogenic medium. In addition,
Go et al. (2016) [27] proved that amnion/chorion membrane extract
can enhance the diﬀerentiation of cells cultured in osteogenic induction
medium into osteoblast cells. This was due to upregulation of osteogenic gene expression (osteocalcin, osteopontin, runt domain-containing transcription factor and osterix), alkaline phosphatase activity
and numerous growth factors including ﬁbroblast growth factor and
transforming growth factors. So the aim of the present work was to
study eﬀect of human amniotic membrane on healing of bone defect in
rabbit's femur.
In our study, rabbits were used as an animal model. Rabbits are easy
to obtain and house. Neyt et al. (1998) stated that rabbits are considered the ﬁrst choice of animal models used in musculoskeletal research [28].Moreover, rabbits have a more rapid bone remodeling rate
in comparison to primates and some rodents [29]. Wang et al. (1998)
found that fracture toughness and bone mineral density of rabbits are
very close to those of human [30]. In the present work, we have chosen
the femur because its size is suitable to create bone defect and its accessibility for surgical procedure.
Histological results of the present study revealed that the defect site
which were ﬁlled with the amniotic membrane showed much less bone
formation in comparison to the control group. Few and thin bony trabecula were seen extending from the defect margins and the central
part contained folded remnant of the membrane surrounded by inﬂammatory cells. Our ﬁndings contradict those of Ríos et al. (2014)
who investigated the eﬀect of Lyophilized amniotic membrane or collagen on bone defect healing in rabbit femur. They found that defects
covered with amniotic membrane showed a higher bone density and
new bone formation in comparison to those covered with collagen
membrane [31].
In addition, Kerimog˘lu et al. (2009) found that human amniotic
ﬂuid can enhance tibia fracture healing in rats when instilled directly
into the fracture line. They observed the highest score at the study
group in comparison to the control. At the ﬁfth week the fracture site
was ﬁlled with woven bone and some cartilage. This can be attributed
to the composition of the human amniotic ﬂuid which contains hyaluronic acid many growth factors including epidermal growth factor
(EGF), ﬁbroblast growth factor (FGF),insulin-like growth factors I and II
(IGF-I and IGFII) [32].
Amniotic
membrane
has
anti-inﬂammatory
properties.
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Samandariet al (2011) found that human amniotic membrane can improve bone formation, decrease inﬂammation and exudate formation
after vestibuloplasty in dogs [33].
Moreover, a clinical trial made by Kumar et al. (2015) to evaluate
the use of amniotic membrane with bone graft in treatment of interdental defects. The amniotic membrane increased the amount of bone
ﬁll and decreased the inﬂammation indicated by decrease in the levels
of interleukin 1β in gingival crevice ﬂuid [34].
Interestingly, Go et al. (2017) examined the eﬀect of each of amniotic and chorion membrane extracts (AME &CME) on osteoblast like
cells diﬀerentiation in vitro. They found that both extracts can enhance
the osteogenic diﬀerentiation of cells in vitro but the CME was more
eﬃcient. AME contained epidermal growth factor (EGF) which negatively regulated the osteogenic diﬀerentiation of cells in vitro. Co-culture of EGF withCME led to decrease in mineralization of extracellular
matrix of osteogenic cells in vitro [35].
In our study the histomorphometrical analysissupported our histological results. There was signiﬁcant decrease in mean bone surface
area in the amniotic membrane group in relation to the control group.
Contrary to our results, Starecki et al. (2014)found that the use of
amniotic membrane can enhance new bone formation in femoral bone
defect in rats. In defects ﬁlled with bone graft mixed with amnioticderived tissue the amount of new bone formation was 49.2%, while in
defects ﬁlled with bone graft alone, the newly formed bone was 37.8%
only [36].
Our results contradict the previous studies which support the positive
eﬀect of amniotic membrane in enhancing bone formation. This may be
attributed to several factors; ﬁrstly using the freeze dried form of the
membrane in our study instead of the fresh one containing stem cells
with regenerative potential. Also, the main and well known use of the
amniotic membrane is in repair of wounds and burn lesions due to its reepithelialization capacity rather than healing of bone defects. Moreover,
the previous studies investigating its use in bone defects, have either used
it in combination with bone graft [36]or as a covering membrane for the
defect [31]. Using it as a sole ﬁlling material for the bone defect in the
current study might have induced inﬂammatory processes leading to
retardation of healing compared to the control group.
So, in conclusion our results don't support the initial hypothesis that
the use of freeze dried amniotic membrane as a ﬁlling material may
potentiate healing of bone defects. And we recommend further studies
to either conﬁrm or oppose our results.
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